Scientists_edited.jpg

A NEW GENERATION OF IMMUNOTHERAPIES

AyuVis Research, Inc. is developing a new generation of immunotherapies that, rather than simply activating or suppressing the immune response,

 provide a well-balanced outcome where both mild activation and controlled suppression of the immune system is needed to effectively treat disease.

This process allows us to control both inflammation and infection.

Our drug candidates were designed with 3 things in mind, being: 

  1. Easy to manufacture 

  2. Simple to formulate

  3. Safe with no toxicity in humans

Unlike these previous generations of immunotherapy, AyuVis compounds target the white blood cells in the innate immune system to provide a rapid response 

Immunotherapies for autoimmune diseases and cancer have annual worldwide sales of more than: 

$70 Billion  

OUR SCIENCE

Click the button to see our science

AyuVis group photo_edited_edited.jpg

OUR TEAM

Click the button to meet our top team of scientists, advisors, and administrators

Our Team

OUR NEWS & EVENTS

Keep up with the latest busines and scientific progress

News & Events
stock-photo-pencil-placed-on-scientific-journal-paper-with-highlight-color-1019265877_edit
2022-04-18_edited.jpg

OUR PIPELINE

A pipeline like no other